A study to find out if fezolinetant helps reduce moderate to severe hot flashes in women in Asia going through menopause

Trial Identifier: 2693-CL-0305
Sponsor: Astellas Pharma China, Inc.
Start Date: March 2020
Primary Completion Date: April 2022
Study Completion Date: April 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations